Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.665
+0.055 (3.42%)
Feb 4, 2025, 12:09 PM EST
Talis Biomedical Company Description
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.
Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Talis Biomedical Corporation
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 99 |
| CEO | Robert Kelley |
Contact Details
Address: 1375 West Fulton Market Chicago, Delaware 60607 United States | |
| Phone | 650 433 3000 |
| Website | talisbio.com |
Stock Details
| Ticker Symbol | TLIS |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US87424L1089 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Rebecca Markovich | Interim Chief Financial Officer |
| Liang Li Ph.D. | Co-Founder and Director of Technology and Strategy |
| Margaret Barrett M.S. | Controller |
| Gillian Green | Company Secretary |